Cytarabine for Injection, 1 gm/vial [Bedford Labs]: Recall: Risk of Lack of Sterility
Providers should not use the product lots listed for patient care and should immediately quarantine any product for return
Undefined
Providers should not use the product lots listed for patient care and should immediately quarantine any product for return
Difficulty disconnecting accessories from the tube may result may result in dislodgement of tube and could lead to serious patient injury or death
Affects device and software that aids in the identification and mapping of areas of the brain.
Reports of dosing syringe flow restrictor being pushed into the bottle when inserting the syringe.
Brush head may break off in the user’s mouth or near the face, causing cuts to the mouth and gums, chipped or broken teeth, swallowing and choking on the broken pieces, and injuries to the face and eyes.
Disponibili on line raccomandazioni conclusive relative ai 12 medicinali autorizzati con procedura centralizzata prodotti presso il sito Ben Venue Laboratories.
Nel documento di domande e risposte, nuove e importanti informazioni di sicurezza su Vivaglobin (immunoglobulina normale umana per uso sottocutaneo)
L’Agenzia Italiana del Farmaco rende disponibili on line nuove e importanti informazioni sui medicinali a base di aliskiren.
L’Agenzia Italiana del Farmaco rende disponibili on line nuove e importanti informazioni su medicinali anti-tubercolosi.
Disponibili on line nuove e importanti informazioni su medicinali anti-tubercolosi.
80.211.154.110